EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice

Amin Mehrabian, Saba Dadpour iD, Mohammad Mashreghi, Javad Zarqi, Anis Askarizadeh, Ali Badiee, Leila Arabi, Seyedeh Alia Moosavian, Mahmoud Reza Jaafari

IET Nanobiotechnology · 2023

DOI: 10.1049/nbt2.12111 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IET Nanobiotechnology, 2023. Verfasst von Amin Mehrabian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Brain, Doxorubicin. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several obstacles limit the efficacy of brain tumour treatment, most notably the blood‐brain barrier (BBB), which prevents the brain uptake of the majority of accessible medicines due to tight junctions. The presence of glutathione (GSH) receptors on the BBB surface has been demonstrated in numerous papers; consequently, products containing glutathione as a targeting ligand coupled with nanoliposomes are used to enhance drug delivery across the BBB. Here, the 5% pre‐inserted PEG2000‐GSH PEGylated liposomal doxorubicin was conducted according to 2B3‐101 being tested in clinical trials. In addition, PEGylated nanoliposomal doxorubicin connected to the spacer‐GSH targeting ligand (GSGGCE) and the PEG3400 was conducted using post‐insertion method. Next, in vivo biodistribution of the produced formulations was tested on healthy mice to see if GSGGCE, as the targeted ligand, could cross the BBB compared to 5% pre‐inserted PEG2000‐GSH and Caelyx ® . Compared to the pre‐inserted formulation and Caelyx ® , the post‐inserted formulations' concentration was lower in the heart and higher in brain tissues, resulting in boosting the brain concentration of accumulated doxorubicin with fewer possible side effects, including cardiotoxicity. In comparison to the pre‐insertion procedure, the post‐insertion method is easier, faster, and more cost‐effective. Moreover, employing PEG3400 and the post‐insertion approach in the PEG3400‐GSGGCE liposomal formulations was found to be effective in crossing the BBB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainDoxorubicinMiceAnimalsTissue DistributionLigandsDrug Delivery SystemsLiposomesPolyethylene GlycolsGlutathione

Stichwörter der Autor:innen

braindrug delivery systemsnanomedicinenanoparticles

Substanzen

liposomal doxorubicinLigandsDoxorubicinLiposomesPolyethylene GlycolsGlutathione

Autor:innen und Institutionen

  • Department of Pharmaceutical Nanotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Nanotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Nanotechnology Research Center, Student Research Committee, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

ORCID-Profile: Saba Dadpour

Förderung

  • Mashhad University of Medical Sciences

Zitieren

APA

Mehrabian, A., Dadpour, S., Mashreghi, M., Zarqi, J., Askarizadeh, A., Badiee, A., Arabi, L., Moosavian, S. A., & Jaafari, M. R. (2023). The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice. IET Nanobiotechnology. https://doi.org/10.1049/nbt2.12111

Vancouver

Mehrabian A, Dadpour S, Mashreghi M, Zarqi J, Askarizadeh A, Badiee A, et al. The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice. IET Nanobiotechnology. 2023. doi:10.1049/nbt2.12111

BibTeX
@article{Mehrabian2023,
  author = {Mehrabian, Amin and Dadpour, Saba and Mashreghi, Mohammad and Zarqi, Javad and Askarizadeh, Anis and Badiee, Ali and Arabi, Leila and Moosavian, Seyedeh Alia and Jaafari, Mahmoud Reza},
  title = {The comparison of biodistribution of glutathione PEGylated nanoliposomal doxorubicin formulations prepared by pre‐insertion and post‐insertion methods for brain delivery in normal mice},
  journal = {IET Nanobiotechnology},
  year = {2023},
  doi = {10.1049/nbt2.12111}
}
Kostenlos starten →